Home › Agent Hub › Agent Tools › Part D coverage by drug › Eplerenone
Agent Tools
Eplerenone is a generic drug. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,490 of 5,492 Medicare Part D and Medicare Advantage drug plans (81.8%) list Eplerenone on their formulary, across 258 of 286 formularies. The most common placement is tier 3 (2,113 plans, 47.1% of those covering it). 0 of the covering plans require prior authorization (0%), 18 step therapy and 0 a quantity limit.
1,203 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $0, 658 of them $0; 3,287 charge coinsurance instead — median 25% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 4,439 of 5,496 plans covered it (80.8%); 2027: 4,490 of 5,492 (81.8%).
Of 4,367 plans offered in both years, 2 added it to the formulary and 12 dropped it.
Among plans covering it both years, 349 moved it to a higher tier and 279 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 447 |
| Tier 2 | 759 |
| Tier 3 | 2,113 |
| Tier 4 | 1,171 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 172 of 323 | 53.3% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,598 of 3,200 | 81.2% | 0% |
| Special needs plans (SNP) | 1,720 of 1,969 | 87.4% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 0 of 846 | No tier listed | 0 |
| UnitedHealthcare | 830 of 830 | Tier 3 | 0 |
| Devoted Health | 728 of 728 | Tier 3 | 0 |
| Aetna Medicare | 631 of 631 | Tier 4 | 0 |
| Wellcare | 268 of 268 | Tier 1 | 0 |
| HealthSpring | 186 of 226 | Tier 3 | 0 |
| Kaiser Permanente | 112 of 112 | Tier 2 | 0 |
| SCAN Health Plan | 83 of 83 | Tier 3 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 4 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 3 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 4 | 0 |
| Wellpoint | 63 of 63 | Tier 4 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 4 | 0 |
| CarePlus Health Plans, Inc. | 0 of 37 | No tier listed | 0 |
| Zing Health | 36 of 36 | Tier 2 | 0 |
| Capital Blue Cross | 35 of 35 | Tier 4 | 0 |
| Prominence Health Plan | 29 of 29 | Tier 4 | 0 |
| Medica | 27 of 27 | Tier 3 | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 4 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 4 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 91 of 114 | 79.8% |
| Alaska | 5 of 9 | 55.6% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 124 of 147 | 84.4% |
| Arkansas | 63 of 85 | 74.1% |
| California | 365 of 397 | 91.9% |
| Colorado | 86 of 106 | 81.1% |
| Connecticut | 46 of 54 | 85.2% |
| Delaware | 35 of 43 | 81.4% |
| District of Columbia | 11 of 12 | 91.7% |
| Florida | 388 of 545 | 71.2% |
| Georgia | 113 of 149 | 75.8% |
| Guam | 1 of 1 | 100% |
| Hawaii | 41 of 50 | 82% |
| Idaho | 30 of 45 | 66.7% |
| Illinois | 102 of 132 | 77.3% |
| Indiana | 107 of 138 | 77.5% |
| Iowa | 53 of 64 | 82.8% |
| Kansas | 62 of 84 | 73.8% |
| Kentucky | 78 of 121 | 64.5% |
| Louisiana | 88 of 125 | 70.4% |
| Maine | 36 of 52 | 69.2% |
| Maryland | 41 of 49 | 83.7% |
| Massachusetts | 81 of 89 | 91% |
| Michigan | 164 of 182 | 90.1% |
| Minnesota | 49 of 63 | 77.8% |
| Mississippi | 79 of 104 | 76% |
| Missouri | 135 of 170 | 79.4% |
| Montana | 8 of 27 | 29.6% |
| Nebraska | 38 of 51 | 74.5% |
| Nevada | 80 of 100 | 80% |
| New Hampshire | 15 of 25 | 60% |
| New Jersey | 59 of 73 | 80.8% |
| New Mexico | 52 of 68 | 76.5% |
| New York | 195 of 215 | 90.7% |
| North Carolina | 146 of 176 | 83% |
| North Dakota | 21 of 26 | 80.8% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 148 of 171 | 86.5% |
| Oklahoma | 56 of 81 | 69.1% |
| Oregon | 78 of 92 | 84.8% |
| Pennsylvania | 295 of 323 | 91.3% |
| Puerto Rico | 62 of 64 | 96.9% |
| Rhode Island | 20 of 29 | 69% |
| South Carolina | 65 of 89 | 73% |
| South Dakota | 25 of 30 | 83.3% |
| Tennessee | 132 of 156 | 84.6% |
| Texas | 336 of 407 | 82.6% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 37 of 53 | 69.8% |
| Vermont | 6 of 14 | 42.9% |
| Virginia | 99 of 144 | 68.8% |
| Washington | 94 of 114 | 82.5% |
| West Virginia | 51 of 69 | 73.9% |
| Wisconsin | 76 of 96 | 79.2% |
| Wyoming | 6 of 13 | 46.2% |
Medicare Part D paid for 738,082 30-day fills of Eplerenone in 2024 for about 83,301 enrollees, at an average total cost of $36.48 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Eplerenone and the rest of a client's list on every plan in their county.
Estimate Eplerenone costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.